Positive effect of review and approval system reform on clinical trialsNI Na, CUI Ran-ran, ZHENG Yan, DENG hong-zhi, ZHOU Bin1825-1829
Trends of new drug R&D and approval by FDA: an analysis of the data of application of new molecular entities from 1985 to 2019BAI Lin, FAN Ping-an, SHI Lu-wen, CHEN Jing1830-1835
A new drug for treatment of mantle cell lymphoma:Bruton's tyrosine kinase inhibitor-zanubrutinibWANG Chun-hui, ZHANG Xue-jiao, Lü Qian-zhou1836-1840
A new treatment option of inflammatory bowel disease:gut selective integrin inhibitor-vedolizumabLI Hui-bo, LIU Fang, ZHAI Suo-di1841-1845
Review and analyses of progress and safety monitoring of clinical trials of COVID-19PEI Xiao-jing, WANG Hai-xue, WANG Tao1846-1849
Research progress in HIV reverse transcriptional inhibitors acting on apoliprotein B mRNA-editing enzyme catalytic polypetide proteinLI Jun-jie, LUO Rong-hua, YANG Liu-meng, WANG Ting, MA Wen-jie, HUANG Ning1855-1860
Application of high content analysis in the study of toxicity mechanism of drug mitochondrial damageSONG Jia-min, WANG Meng, CHEN Mei-ling1861-1866
Efficacy and safety of clindamycin hydrochloride palmitate dispersion tablets for treatment of chronic periodontitisZHANG Jing, ZHENG Jing-jing, WU Ying, WU Min1867-1870
Exploration on increasing administration accuracy of injectable new drugs in Phase Ⅰ clinical trialsYANG Dan-dan, JIANG Bo, HU Yin, GUAN Yan-lu, JIANG Qian-qian, RUAN Zou-rong1871-1874